Close
  Indian J Med Microbiol
 

Figure 2: The sequential optical coherence tomography during the treatment. (a) Optical coherence tomography showed improved macular edema after 1st injection of aflibercept with central retinal thickness of 312 μm. (b) Optical coherence tomography showed recurrent cystoid macular edema 2 month after 1st injection of aflibercept with central retinal thickness of 363 μm. (c) Optical coherence tomography showed improved macular edema the next month after 2nd injection of aflibercept with central retinal thickness of 301 μm. (d) Optical coherence tomography showed recurrent cystoid macular edema and subretinal fluid 3 months after 2nd injection of aflibercept with central retinal thickness of 363 μm

Figure 2: The sequential optical coherence tomography during the treatment. (a) Optical coherence tomography showed improved macular edema after 1<sup>st</sup> injection of aflibercept with central retinal thickness of 312 μm. (b) Optical coherence tomography showed recurrent cystoid macular edema 2 month after 1<sup>st</sup> injection of aflibercept with central retinal thickness of 363 μm. (c) Optical coherence tomography showed improved macular edema the next month after 2<sup>nd</sup> injection of aflibercept with central retinal thickness of 301 μm. (d) Optical coherence tomography showed recurrent cystoid macular edema and subretinal fluid 3 months after 2<sup>nd</sup> injection of aflibercept with central retinal thickness of 363 μm